www.Top100Medicine.com - TOP 100 MEDICAL SITES
TOP 100 MEDICAL SITES
 Main  |  Add a Site  |  FREE Content for Your Web-site  |  Bookmark this site  |  Webmaster 
Updated Sat, February 4, 2012.
401.www.zhkplus.de4460
402.www.virginiamason.org4390
403.www.anoiksis.nl4360
404.www.snfge.asso.fr4300
405.www.zonamedica.com.ar4300
406.www.cdbx.org4290
407.www.derma.de4280
408.www.swissheart.ch4280
409.www.unimo.it4270
410.www.saintluc.be4230
411.www.augen.de4210
412.www.kinderradiologie-online.de4210
413.www.mc.duke.edu4110
414.www.medito.com4110
415.www.lapelle.it4020
416.www.armymedicine.army.mil4020
417.www.med.unipi.it4010
418.www.paidopsiquiatria.com4010
419.www.mpimf-heidelberg.mpg.de3980
420.www.anatomie.net3930
421.www.chu-brugmann.be3920
422.www.simg.it3860
423.www.srlf.org3800
424.www.stethonet.org3790
425.www.nki.nl3740
426.www.yestheyrefake.net3670
427.www.tutorat-medecine-lille.com3670
428.www.anmco.it3670
429.www.hautstadt.de3660
430.www.azm.nl3650
431.www.jim.fr3640
432.www.klinik.uni-frankfurt.de3630
433.www.pneumotox.com3620
434.www.best-med-link.de3550
435.www.anapath.necker.fr3540
436.www.dgkj.de3490
437.www.mydrg.de3480
438.www.zahnheilkunde.de3480
439.www.ior.it3480
440.www.ibmt.fraunhofer.de3430
441.www.psychowijzer.nl3430
442.www.dermatonet.com3410
443.www.medcost.fr3410
444.www.ser.es3410
445.www.dgzmk.de3370
446.www.uhhs.com3330
447.www.doctoroogle.com3300
448.www.cirugest.com3270
449.www.intermedicina.com3250
450.www.lzk-bw.de3230
Pages:  1  2  3  4  5  6  7  8  9  10  11  12 
 13  14  15  16 



Subscribe to RSS feed Subscribe to Feed Burner feed Add to Del.icio.us Add to Yahoo Add to Google Add to Reddit Add to Blink Add to Meneame Add to Fark Add to Newsvine

403. www.anoiksis.nl

Rating: 4360 points*
*amount mentions of word 'www.anoiksis.nl' on the other websites

www.anoiksis.nl

Anoiksis, de vereniging van mensen met een schizofrene of psychotische stoornis

Description: Anoiksis, de vereniging van mensen met een schizofrene of psychotische stoornis.

Google

© 2005-2012 www.Top100Medicine.com
The Cancer Risk for Purebred Dogs
Numerous research projects are under way to try to identify genes that predispose purebred dogs to cancer. In the meantime, lifestyle choices can help reduce their risk.
online.wsj.com
Spherix Expands Development Strategy for D-Tagatose (PR Newswire)
Spherix Incorporated , an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that it will explore triglycerides as a potential therapeutic opportunity for its D-tagatose therapy, pending a review of data from a Phase 3 clinical trial the Company is conducting on the use of D-tagatose as a treatment for Type 2 diabetes.  Reduction of triglyceride levels is a secondary endpoint of the Phase 3 trial.  Results from the trial are expected later this summer.
us.rd.yahoo.com
Baxter's Profit Drops 8.9%
Baxter International's second-quarter earnings fell 8.9%, including a charge, as it faced macroeconomic headwinds and individual product issues.
online.wsj.com
RadNet Enters the Radiology Software Business: Acquires eRAD, Inc. and Assembles an Industry-Leading Radiology Software Team
[GlobeNewswire] - LOS ANGELES -- RadNet, Inc. , a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 191 fully-owned and operated outpatient imaging centers, today reported it has executed a definitive agreement to acquire Image Medical Corporation, the parent of eRAD, Inc., for $10.75 million in a combination of cash and promissory notes.
us.rd.yahoo.com
Glaxo Meets Big Disappointment in Failed Herpes Vaccine
Pharmalot submits: An effort that began eight years ago to develop a herpes simplex vaccine for women has ended in failure and uncertainty. After assessing final Phase III trial results, the GlaxoSmithKline (GSK) vaccine, known as Simplirix, failed to meet its primary endpoint, which was preventing genital herpes. However, it remains unclear why the vaccine was not effective. Safety issues were not cited as a problem. The outcome is a huge disappointment for the drugmaker, which has been attempting to expand its portfolio of vaccine products, given that an estimated one in four women in the US alone has genital herpes. In other words, the afflication is one of the most common infectious diseases and that can translate into huge revenues.Complete Story »
seekingalpha.com